Drug | Pooled sensitivity (%) (95% CI) | Pooled specificity (%) (95% CI) | Prevalence of drug resistance [10] (%) | PPV (%) (95% CI) | NPV (%) (95% CI) |
---|---|---|---|---|---|
INH | 91.3 (82.0–96.7) | 100.0 (86.3–100.0) | 15.5 | 100.0 (100.0–100.0) | 98.4 (96.7–99.3) |
RFP | 98.0 (89.1–99.9) | 98.0 (89.6–100.0) | 9.3 | 83.7 (42.4–97.3) | 99.8 (98.5–100.0) |
EMB | 96.7 (87.8–99.9) | 90.0 (80.5–95.9) | 6.7 | 41.0 (25.5–58.4) | 99.7 (98.2–100.0) |
PZA | 65.0 (40.8–84.6) | 96.3 (89.4–99.2) | 4.3 | 43.8 (19.7–71.2) | 98.4 (97.1–99.1) |
SM | 62.1 (42.3–79.3) | 98.6 (92.4–100.0) | 5.4 | 71.6 (26.0–94.7) | 97.9 (96.6–98.6) |
AMK, KM | 0.0 (0.0–70.8) | 100.0 (96.3–100.0) | 2.2 | N/A | 97.8 (97.8–97.8) |
FQ | 66.7 (34.9–90.1) | 100.0 (95.9–100.0) | 2.9 | 100.0 (100.0–100.0) | 99.0 (97.8–99.6) |